Rational Formulation of targeted ABT-737 nanoparticles by self-assembled polypeptides and designed peptides.

Area of Science:

• Biotechnology
• Materials Science
• Nanomedicine

Background:

• Mitochondria play a key role in apoptosis, and targeting antiapoptotic proteins like Bcl-2 is a strategy for cancer therapy.
• ABT-737 is a potent Bcl-2 inhibitor, but effective drug delivery remains a challenge.

Purpose of the Study:

• To develop and optimize nanoparticle formulations for targeted delivery of ABT-737 to mitochondria.
• To investigate the influence of formulation parameters on nanoparticle stability and drug efficacy.
• To evaluate the cytotoxic effect of the optimized nanoparticles on MDA-MB-231 cancer cells.

Main Methods:

• Self-assembly of nanoparticles using poly gamma glutamic acid (ϒPGA) and a peptide (PFK).
• Loading of ABT-737 into the developed nanoparticles.
• Systematic optimization of formulation parameters including pH, component concentrations, and mixing sequence.
• Assessment of nanoparticle stability and in vitro cytotoxicity assays on MDA-MB-231 cells.

Main Results:

• Successfully developed stable nanoparticles capable of encapsulating ABT-737.
• Identified optimal formulation conditions (pH, component ratios, mixing order) for enhanced stability and drug loading.
• Demonstrated significant cytotoxic effects of the optimized nanoparticles on MDA-MB-231 cells, indicating effective mitochondrial targeting.

Conclusions:

• Designed peptide-biopolymer nanoparticles offer a promising platform for targeted drug delivery of ABT-737.
• Formulation parameters critically influence the performance of these nanoparticles for cancer therapy.
• This approach highlights the potential of engineered peptides and biopolymers in advanced drug delivery systems.